☆ 4.5 Editorial Material

How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?

EXPERT OPINION ON DRUG DISCOVERY (2023)

Journal

EXPERT OPINION ON DRUG DISCOVERY

Volume 18, Issue 10, Pages 1061-1064

Publisher

TAYLOR & FRANCIS LTD

DOI: 10.1080/17460441.2023.2236930

Keywords

Artificial intelligence; computer-aided drug design; COVID-19; drug discovery; machine learning

Categories

Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.